Philip Arlen

Philip Arlen

Company: Precision BioLogic

Job title: President & Chief Executive Officer


Targeting Tumour Neoepitopes with Monoclonal Antibodies 2:00 pm

Employing a unique cancer vaccine platform to develop monoclonal antibodies against functional tumour neo-antigens Utilising innovative technologies and expertise in immunology, in addition to unique antibody display platforms with an automated high throughput screening Using these antibodies to identify the precise neoantigen targetedRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.